141 related articles for article (PubMed ID: 8669459)
1. Increased hyaluronan at sites of attachment to mesentery by CD44-positive mouse ovarian and breast tumor cells.
Yeo TK; Nagy JA; Yeo KT; Dvorak HF; Toole BP
Am J Pathol; 1996 Jun; 148(6):1733-40. PubMed ID: 8669459
[TBL] [Abstract][Full Text] [Related]
2. Perturbation of hyaluronan interactions by soluble CD44 inhibits growth of murine mammary carcinoma cells in ascites.
Peterson RM; Yu Q; Stamenkovic I; Toole BP
Am J Pathol; 2000 Jun; 156(6):2159-67. PubMed ID: 10854236
[TBL] [Abstract][Full Text] [Related]
3. Pathogenesis of ascites tumor growth: angiogenesis, vascular remodeling, and stroma formation in the peritoneal lining.
Nagy JA; Morgan ES; Herzberg KT; Manseau EJ; Dvorak AM; Dvorak HF
Cancer Res; 1995 Jan; 55(2):376-85. PubMed ID: 7529135
[TBL] [Abstract][Full Text] [Related]
4. Pathogenesis of ascites tumor growth: fibrinogen influx and fibrin accumulation in tissues lining the peritoneal cavity.
Nagy JA; Meyers MS; Masse EM; Herzberg KT; Dvorak HF
Cancer Res; 1995 Jan; 55(2):369-75. PubMed ID: 7812970
[TBL] [Abstract][Full Text] [Related]
5. Induction of apoptosis of metastatic mammary carcinoma cells in vivo by disruption of tumor cell surface CD44 function.
Yu Q; Toole BP; Stamenkovic I
J Exp Med; 1997 Dec; 186(12):1985-96. PubMed ID: 9396767
[TBL] [Abstract][Full Text] [Related]
6. Pathogenesis of ascites tumor growth: vascular permeability factor, vascular hyperpermeability, and ascites fluid accumulation.
Nagy JA; Masse EM; Herzberg KT; Meyers MS; Yeo KT; Yeo TK; Sioussat TM; Dvorak HF
Cancer Res; 1995 Jan; 55(2):360-8. PubMed ID: 7812969
[TBL] [Abstract][Full Text] [Related]
7. Binding of ovarian cancer cells to immobilized hyaluronic acid.
Catterall JB; Gardner MJ; Jones LM; Turner GA
Glycoconj J; 1997 Nov; 14(7):867-9. PubMed ID: 9511993
[TBL] [Abstract][Full Text] [Related]
8. Different pathways of macromolecule extravasation from hyperpermeable tumor vessels.
Feng D; Nagy JA; Dvorak AM; Dvorak HF
Microvasc Res; 2000 Jan; 59(1):24-37. PubMed ID: 10625568
[TBL] [Abstract][Full Text] [Related]
9. Gonadotropin stimulation of MLS human epithelial ovarian carcinoma cells augments cell adhesion mediated by CD44 and by alpha(v)-integrin.
Schiffenbauer YS; Meir G; Maoz M; Even-Ram SC; Bar-Shavit R; Neeman M
Gynecol Oncol; 2002 Feb; 84(2):296-302. PubMed ID: 11812090
[TBL] [Abstract][Full Text] [Related]
10. Hyaluronidase reduces human breast cancer xenografts in SCID mice.
Shuster S; Frost GI; Csoka AB; Formby B; Stern R
Int J Cancer; 2002 Nov; 102(2):192-7. PubMed ID: 12385018
[TBL] [Abstract][Full Text] [Related]
11. Binding of ovarian cancer cells to peritoneal mesothelium in vitro is partly mediated by CD44H.
Cannistra SA; Kansas GS; Niloff J; DeFranzo B; Kim Y; Ottensmeier C
Cancer Res; 1993 Aug; 53(16):3830-8. PubMed ID: 8339295
[TBL] [Abstract][Full Text] [Related]
12. Binding of ovarian cancer cells to immobilized hyaluronic acid.
Catterall JB; Gardner MJ; Jones LM; Turner GA
Glycoconj J; 1997 Aug; 14(5):647-9. PubMed ID: 9298699
[TBL] [Abstract][Full Text] [Related]
13. Expression of the hyaluronan receptor, CD44S, in epithelial ovarian cancer is an independent predictor of survival.
Kayastha S; Freedman AN; Piver MS; Mukkamalla J; Romero-Guittierez M; Werness BA
Clin Cancer Res; 1999 May; 5(5):1073-6. PubMed ID: 10353740
[TBL] [Abstract][Full Text] [Related]
14. Functional heterogeneity of CD44 molecules in ovarian cancer cell lines.
Cannistra SA; DeFranzo B; Niloff J; Ottensmeir C
Clin Cancer Res; 1995 Mar; 1(3):333-42. PubMed ID: 9815989
[TBL] [Abstract][Full Text] [Related]
15. Tumour regulation of fibroblast hyaluronan expression: a mechanism to facilitate tumour growth and invasion.
Edward M; Gillan C; Micha D; Tammi RH
Carcinogenesis; 2005 Jul; 26(7):1215-23. PubMed ID: 15746159
[TBL] [Abstract][Full Text] [Related]
16. Intracellular osteopontin is an integral component of the CD44-ERM complex involved in cell migration.
Zohar R; Suzuki N; Suzuki K; Arora P; Glogauer M; McCulloch CA; Sodek J
J Cell Physiol; 2000 Jul; 184(1):118-30. PubMed ID: 10825241
[TBL] [Abstract][Full Text] [Related]
17. Pathogenesis of malignant ascites formation: initiating events that lead to fluid accumulation.
Nagy JA; Herzberg KT; Dvorak JM; Dvorak HF
Cancer Res; 1993 Jun; 53(11):2631-43. PubMed ID: 8495427
[TBL] [Abstract][Full Text] [Related]
18. Hyaluronan on the surface of tumor cells is correlated with metastatic behavior.
Zhang L; Underhill CB; Chen L
Cancer Res; 1995 Jan; 55(2):428-33. PubMed ID: 7529138
[TBL] [Abstract][Full Text] [Related]
19. High levels of stromal hyaluronan predict poor disease outcome in epithelial ovarian cancer.
Anttila MA; Tammi RH; Tammi MI; Syrjänen KJ; Saarikoski SV; Kosma VM
Cancer Res; 2000 Jan; 60(1):150-5. PubMed ID: 10646867
[TBL] [Abstract][Full Text] [Related]
20. CD44 attenuates metastatic invasion during breast cancer progression.
Lopez JI; Camenisch TD; Stevens MV; Sands BJ; McDonald J; Schroeder JA
Cancer Res; 2005 Aug; 65(15):6755-63. PubMed ID: 16061657
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
